Antenatal taurine reduces cerebral cell apoptosis in fetal rats with intrauterine growth restriction

NewsGuard 100/100 Score

Increased brain cell apoptosis in intrauterine growth-restricted fetal rats is a key reason for unfavorable long-term prognosis of the nervous system. The harmful effects of intrauterine growth restriction on fetal brain development originate in the womb. Therefore, it is difficult to obtain ideal outcomes through postnatal intervention. Taken together, active prenatal intervention is of great importance to the optimal prognosis of the intrauterine growth restricted fetus.

Prof. Jing Liu and colleagues from the General Hospital of Beijing Military Command found that taurine supplement reduces cell apoptosis through the glial cell line-derived neurotrophic fac-tor-caspase-3 signaling pathway, resulting in a protective effect on the intrauterine growth-restricted fetal rat brain. Their experimental results, published in the Neural Regeneration Research (Vol. 8, No. 23, 2013), provided theoretical evidence for preventing or lessening brain injury and promoting brain development in intrauterine growth-restricted fetuses using a suitable measurement before parturition.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel immune cell therapy may be a promising strategy for combating HBV infection